Clinical Trial Update: O6-benzylguanine and Carmustine in Treating Patients With Unresectable Locally Recurrent or Metastatic Melanoma [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating the combination of O6-benzylguanine and Carmustine in patients with unresectable locally recurrent or metastatic melanoma has complet…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• Carmustine (carmustine)
• O6-Benzylguanine (O6-Benzylguanine)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Melanoma (Skin) | Phase 2 | Status: COMPLETED